glp 1 tri What GLP‑3 Really Is: Retatrutide Triple‑Receptor Drug 1 producing cells in the gut Designing Poly-agonists for Treatment of

The foundational research here traces back to Loren Pickart, whose decades of work culminated in a widely cited 2018 review in the International Journal of Molecular Sciences documenting that GHK-Cu modulates the activity of thousands of human genes tied to tissue remodeling, antioxidant defense, and inflammatory regulation

Any thrombotic events occurring in this population are more likely related to these pre-existing risk factors rather than the medication itself

And theres hope that as more pharmaceutical companies develop their own versions of these drugs, competition will drive prices down

If youre on Ozempic, Wegovy, Mounjaro, or Zepbound, its a fair question